CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
86 hedge funds and large institutions have $98.5M invested in Cascadian Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more capital invested
Capital invested by funds: $98.3M → $98.5M (+$156K)
0% more funds holding
Funds holding: 86 → 86 (0)
Holders
86
Holding in Top 10
2
Calls
$463K
Puts
$201K
Top Buyers
| 1 | +$7.4M | |
| 2 | +$950K | |
| 3 | +$731K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$605K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$594K |
Top Sellers
| 1 | -$7.5M | |
| 2 | -$3.52M | |
| 3 | -$3.12M | |
| 4 |
ERSOT
Employees Retirement System of Texas
Austin,
Texas
|
-$1.71M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$1.34M |